|
NIP Divisions / Branches
Epidemiology &
Surveillance Division (ESD)
The Epidemiology and
Surveillance Division (ESD) is responsible for National Immunization
Program activities regarding the epidemiology, national surveillance,
research and technical consultation for pertussis, diphtheria, tetanus,
polio, measles, mumps, rubella, congenital rubella, varicella, and the
vaccines and toxoids to prevent these diseases. The Division collaborates
with other CDC organizations in the epidemiologic and national
surveillance activities for hepatitis B and Haemophilus Influenzae type b
disease. ESD provides technical assistance, including epidemic aid during
outbreaks of vaccine-preventable diseases, to State and local health
departments, other public health professionals, and to foreign countries.
In collaboration with the Advisory Committee on Immunization Practices
(ACIP), ESD leads NIP efforts in the development of CDC policy to improve
the prevention of extant and new vaccine preventable diseases.
Bacterial
Vaccine-Preventable Diseases Branch
Provides medical and epidemiologic expertise and collaborates with
other CDC organizations and Health and Human Services (HHS)
agencies in developing strategies to enhance immunization coverage of
adults, including influenza, pneumococcal, hepatitis B, measles, mumps,
rubella and varicella vaccines and combined tetanus and diphtheria
toxoids.
Viral
Vaccine-Preventable Diseases Branch
Provides consultation on the use of vaccines and toxoids recommended
for children and the prevention of vaccine preventable diseases.
Conducts national
surveillance and research projects to enhance the use of vaccines and
evaluate the effectiveness of relevant vaccine-preventable disease
activities.
Immunization
Safety Branch
CDC is a leader in immunization safety research
and surveillance assuring vaccine safety
through a multi-faceted approach: CDC vaccine
safety systems identify potential vaccine
side effects through the National Vaccine
Adverse Event Reporting System (VAERS) and
the Vaccine Safety Data Link (VSD). These
large population based systems and other
activities are used to conduct studies to
evaluate whether uncommon adverse health
events following immunization are associated
with a specific vaccine. In order to improve
the scientific understanding of vaccine safety
on the individual level this branch is developing
an academic based network of Clinical Immunization
Safety Assessment Centers (CISA) that can
evaluate individuals who may have experienced
a vaccine related adverse health event. These
Clinical Centers in partnership with CDC
will provide a source of medical expertise
in evaluating and treating adverse events
following immunizations. In addition this
branch is involved in developing new ways
to deliver vaccines safely through new technologies
(needle-free injection practices). Another
critical activity is evaluating public and
health care provider perceptions of vaccination
risk and acceptance to better understand
and help determine appropriate public health
response to vaccine safety concerns.
 Return
to NIP Divisions / Branches main page
|
